Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityLand & ImprovementsLiabilities and Shareholders EquityNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CNL Healthcare Properties (CHTH) Cash & Equivalents (2016 - 2025)

CNL Healthcare Properties (CHTH) has 14 years of Cash & Equivalents data on record, last reported at $57.7 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 14.21% year-over-year to $57.7 million; the TTM value through Sep 2025 reached $57.7 million, up 14.21%, while the annual FY2024 figure was $44.0 million, 18.64% down from the prior year.
  • Cash & Equivalents reached $57.7 million in Q3 2025 per CHTH's latest filing, up from $53.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $94.7 million in Q3 2022 and bottomed at $44.0 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $57.7 million, with a median of $53.5 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 70.52% in 2022, then plummeted 43.52% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $53.2 million in 2021, then soared by 30.74% to $69.5 million in 2022, then decreased by 22.17% to $54.1 million in 2023, then dropped by 18.64% to $44.0 million in 2024, then skyrocketed by 31.09% to $57.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $57.7 million in Q3 2025, $53.2 million in Q2 2025, and $50.9 million in Q1 2025.